Opaleye Management »

Lb Pharmaceuticals shares owned by Opaleye Management

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Opaleye Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $358k 15k 24.66

More positions owned by Opaleye Management

Harrow Health (HROW)
Liquidia Corporation Com New (LQDA)
Eton Pharmaceuticals (ETON)
Sol-gel Technologies Shs New (SLGL)
Rhythm Pharmaceuticals (RYTM)
Apogee Therapeutics (APGE)
Disc Medicine (IRON)
Urogen Pharma (URGN)
Crescent Biopharma (CBIO)
Stoke Therapeutics (STOK)
Perspective Therapeutics Com New (CATX)
Rezolute Com New (RZLT)
Meiragtx Holdings (MGTX)
Tg Therapeutics (TGTX)
Sanuwave Health (SNWV)

View all positions for Opaleye Management

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Trails Edge Capital Partners
Vanguard Group
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Vanguard Capital Management
Alyeska Investment Group
Vivo Capital
Jennison Associates
Geode Capital Management

View all funds holding Lb Pharmaceuticals